February 1, 2018 / 12:38 PM / in 9 months

BRIEF-Mylan Expands Access To HIV/AIDS Medicines With Launch Of First Generic Sustiva Tablets

Feb 1 (Reuters) - Mylan Nv:

* MYLAN EXPANDS ACCESS TO HIV/AIDS MEDICINES WITH LAUNCH OF FIRST GENERIC SUSTIVA® TABLETS

* MYLAN - ANNOUNCED U.S. LAUNCH OF EFAVIRENZ TABLETS USP, 600 MG, FIRST GENERIC VERSION OF BRISTOL-MYERS’ SUSTIVA

* MYLAN NV - CO ELIGIBLE FOR 180 DAYS OF GENERIC DRUG EXCLUSIVITY IN RELATION TO GENERIC SUSTIVA TABLETS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below